- $939.73m
- $791.49m
- $1.11bn
- 76
- 33
- 51
- 53
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.09 | ||
| Price to Tang. Book | 3.9 | ||
| Price to Free Cashflow | 2,624.95 | ||
| Price to Sales | 0.85 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.22% | ||
| Return on Equity | -14.68% | ||
| Operating Margin | -3.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 383.94 | 502.03 | 698.99 | 905.18 | 1,108.61 | 1,256.61 | 1,389.5 | 29.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Trupanion, Inc. is a provider of medical insurance for cats and dogs throughout the United States, Canada, Europe, Puerto Rico, and Australia. The Company operates in two segments: Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises of other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. The Company’s core Trupanion product provides software that is designed to communicate directly with a veterinary hospitals practice management software. It provides Powered by Trupanion pet insurance product offerings marketed by third parties and, in Canada. The Company’s low and medium average revenue per unit (ARPU) products marketed under the brand Furkin and PHI Direct.
Directors
- Murray Low NEC (68)
- Tricia Plouf CPR (42)
- Margaret Tooth CPR (42)
- Darryl Rawlings CEO (52)
- Andrew Wolff CFO (51)
- Gavin Friedman EVP (53)
- Asher Bearman EVP (43)
- Simon Wheeler EVP
- Zay Satchu DRC
- Jacqueline Davidson IND (60)
- Michael Doak IND (45)
- Eric Johnson IND (45)
- Dan Levitan IND (64)
- Howard Rubin IND (68)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 4th, 2006
- Public Since
- July 18th, 2014
- No. of Shareholders
- 29
- No. of Employees
- 1,142
- Sector
- Insurance
- Industry
- Financials
- Exchange
NASDAQ Global Market- Shares in Issue
- 41,858,866
- Address
- 6100 4Th Avenue South, Suite 400, SEATTLE, 98108
- Web
- https://trupanion.com/
- Phone
- +1 8887387478
- Contact
- Laura Bainbridge
- Auditors
- Ernst & Young LLP
Upcoming Events for TRUP
Q1 2024 Trupanion Inc Earnings Call
Trupanion Inc Annual Shareholders Meeting
Q2 2024 Trupanion Inc Earnings Release
Trupanion Inc Investor Day
Similar to TRUP
Atlantic American
NASDAQ Global Market
Fundamental Global
NASDAQ Global Market
Huize Holding
NASDAQ Global Market
MSP Recovery
NASDAQ Global Market
NMI Holdings
NASDAQ Global Market
FAQ
What is the Trupanion share price?
As of Today at 19:23 UTC, shares in Trupanion are trading at $22.45. This share price information is delayed by 15 minutes.
How has the Trupanion share price performed this year?
Shares in Trupanion last closed at $22.45 and the price had moved by -34.53% over the past 365 days. In terms of relative price strength the Trupanion share price has underperformed the S&P500 Index by -45.52% over the past year.
What are the analyst and broker recommendations for Trupanion?
The overall consensus recommendation for Trupanion is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Trupanion dividend yield?
Trupanion does not currently pay a dividend.
Does Trupanion pay a dividend?
Trupanion does not currently pay a dividend.
When does Trupanion next pay dividends?
Trupanion does not currently pay a dividend.
How do I buy Trupanion shares?
To buy shares in Trupanion you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Trupanion?
As of the previous close price of $22.45, shares in Trupanion had a market capitalisation of $939.73m.
Where are Trupanion shares listed?
Here are the trading details for Trupanion:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: TRUP
What kind of share is Trupanion?
Based on an overall assessment of its quality, value and momentum Trupanion is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Trupanion share price forecast for 2024?
The analyst consensus target price for shares in Trupanion is $35.00. That is 55.9% above the last closing price of $22.45.
Analysts covering Trupanion currently have a consensus Earnings Per Share (EPS) forecast of -$0.45 for the next financial year.
What is the trend in the Trupanion share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Trupanion. Over the past six months, its share price has underperformed the S&P500 Index by -16.07%.
As of the last closing price of $22.45, shares in Trupanion were trading -18.15% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Trupanion PE Ratio?
The Trupanion PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $22.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Trupanion?
Trupanion's management team is headed by:
- Murray Low - NEC
- Tricia Plouf - CPR
- Margaret Tooth - CPR
- Darryl Rawlings - CEO
- Andrew Wolff - CFO
- Gavin Friedman - EVP
- Asher Bearman - EVP
- Simon Wheeler - EVP
- Zay Satchu - DRC
- Jacqueline Davidson - IND
- Michael Doak - IND
- Eric Johnson - IND
- Dan Levitan - IND
- Howard Rubin - IND